No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19

BACKGROUND: Some studies have shown that hydroxychloroquine (HCQ) is an effective drug in reducing the in vitro replication of SARS-CoV-2. However, the in vivo effect of HCQ still unclear. OBJECTIVES: This study aims to evaluate viral load clearance in patients with COVID-19 who underwent HCQ treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Faíco-Filho, Klinger Soares, Conte, Danielle Dias, de Souza Luna, Luciano Kleber, Carvalho, Joseane Mayara Almeida, Perosa, Ana Helena Sitta, Bellei, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Clinical Microbiology - Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592126/
https://www.ncbi.nlm.nih.gov/pubmed/33111169
http://dx.doi.org/10.1007/s42770-020-00395-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592126/
https://www.ncbi.nlm.nih.gov/pubmed/33111169
http://dx.doi.org/10.1007/s42770-020-00395-x

Ejemplares similares